HEALTHSTREAM INC
For the period ended Dec 31, 2024. Filed Feb 28, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 28, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on this 28th day of February 2025.
HEALTHSTREAM, INC.
By: /s/ ROBERT A. FRIST, JR.
Robert A. Frist, Jr.
Chief Executive Officer
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed by the following persons on behalf of the registrant and in the capacities and on the dates indicated:
| Signature | Title(s) | Date |
|---|---|---|
| /s/ ROBERT A. FRIST, JR. | Chief Executive Officer and | February 28, 2025 |
| Robert A. Frist, Jr. | Chairman (Principal Executive Officer) | |
| /s/ SCOTT A. ROBERTS | Chief Financial Officer and Senior Vice President | February 28, 2025 |
| Scott A. Roberts | (Principal Financial and Accounting Officer) | |
| /s/ THOMPSON DENT | Director | February 28, 2025 |
| Thompson Dent | ||
| /s/ FRANK GORDON | Director | February 28, 2025 |
| Frank Gordon | ||
| /s/ TERRY ALLISON RAPPUHN | Director | February 28, 2025 |
| Terry Allison Rappuhn | ||
| /s/ JEFFREY L. MCLAREN | Director | February 28, 2025 |
| Jeffrey L. McLaren | ||
| /s/ LINDA REBROVICK | Director | February 28, 2025 |
| Linda Rebrovick | ||
| /s/ ALEX JAHANGIR | Director | February 28, 2025 |
| Alex Jahangir | ||
| /s/ WILLIAM STEAD | Director | February 28, 2025 |
| William Stead | ||
| /s/ DEBORAH TAYLOR TATE | Director | February 28, 2025 |
| Deborah Taylor Tate | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.